MapLight Therapeutics Income Statement (2024-2025) | MPLT

Income Statement Sep2024 Dec2024 Sep2025 Dec2025
Operating items
Research & Development (Quarter) 16.81M20.71M27.09M64.62M
Selling, General & Administrative (Quarter) 4.08M2.06M4.40M18.75M
Other Operating Expenses (Quarter) 63.99M-177.01M
Operating Expenses (Quarter) 20.89M86.76M31.50M-93.64M
Operating Income (Quarter) -20.89M-22.78M-31.50M-83.38M
EBIT (Quarter) -20.89M-22.78M-31.50M-83.38M
Non-operating items
Interest & Investment Income (Quarter) 1.08M0.90M1.55M2.47M
Other Non Operating Income (Quarter) 0.80M0.65M0.53M1.36M
Non Operating Income (Quarter) 1.88M1.55M2.08M3.83M
Net income details
EBT (Quarter) -20.11M-21.58M-34.07M-81.21M
Profit After Tax (Quarter) -19.02M-21.23M-29.42M-79.55M
Income from Continuing Operations (Quarter) -20.11M-21.58M-34.07M-81.21M
Consolidated Net Income (Quarter) -20.11M-21.58M-34.07M-81.21M
Income towards Parent Company (Quarter) -20.11M-21.58M-34.07M-81.21M
Net Income towards Common Stockholders (Quarter) -20.11M-21.58M-34.07M-81.21M
Additional items
EPS (Basic) (Quarter) -26.53-29.31-43.06-9.35
EPS (Diluted) (Quarter) -26.53-29.31-43.06-9.35
Shares Outstanding (Quarter) 0.76M0.74M0.79M8.68M
Shares Outstanding (Diluted) (Quarter) 0.76M0.74M0.79M8.68M
EBITDA (Quarter) -20.89M-22.78M-31.50M-83.38M
Interest Expenses (Quarter) 0.30M-0.30M4.12M0.30M